Latest Insider Transactions at Applied Therapeutics Inc. (APLT)
This section provides a real-time view of insider transactions for Applied Therapeutics Inc. (APLT). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Applied Therapeutics Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Applied Therapeutics Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2021
|
Charles Silberstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
5,047
-5.44%
|
$105,987
$21.42 P/Share
|
|
Jun 07
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-71.74%
|
$9,200
$20.91 P/Share
|
|
Jun 07
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
|
Jun 04
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$8,740
$19.65 P/Share
|
|
Jun 04
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
|
Jun 03
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$8,740
$19.66 P/Share
|
|
Jun 03
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
|
May 26
2021
|
Adam Hansard Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
2,894
-7.94%
|
$52,092
$18.35 P/Share
|
|
May 26
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$8,740
$19.43 P/Share
|
|
May 26
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
|
May 25
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$7,820
$17.97 P/Share
|
|
May 25
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
|
May 24
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,640
-100.0%
|
$27,880
$17.25 P/Share
|
|
May 24
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,640
+50.0%
|
$1,640
$1.44 P/Share
|
|
May 11
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
200
-100.0%
|
$3,400
$17.27 P/Share
|
|
May 11
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+50.0%
|
$200
$1.44 P/Share
|
|
May 10
2021
|
Chids Mahadevan Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,544
+50.0%
|
-
|
|
Apr 30
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$8,280
$18.32 P/Share
|
|
Apr 30
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
|
Apr 29
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$8,280
$18.28 P/Share
|
|
Apr 29
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
|
Apr 28
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,640
-90.85%
|
$29,520
$18.63 P/Share
|
|
Apr 28
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,640
+50.0%
|
$1,640
$1.44 P/Share
|
|
Apr 14
2021
|
Joel S Marcus |
BUY
Exercise of conversion of derivative security
|
Indirect |
98,959
+39.95%
|
$494,795
$5.23 P/Share
|
|
Apr 14
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
200
-100.0%
|
$3,400
$17.11 P/Share
|
|
Apr 14
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
200
+50.0%
|
$200
$1.44 P/Share
|
|
Mar 30
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
460
-100.0%
|
$8,280
$18.43 P/Share
|
|
Mar 30
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
460
+50.0%
|
$460
$1.44 P/Share
|
|
Mar 29
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$8,370
$18.53 P/Share
|
|
Mar 29
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
|
Mar 26
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$8,835
$19.68 P/Share
|
|
Mar 26
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
|
Mar 15
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$8,835
$19.61 P/Share
|
|
Mar 15
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
|
Mar 12
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$8,835
$19.38 P/Share
|
|
Mar 12
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
|
Mar 11
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$8,370
$18.48 P/Share
|
|
Mar 11
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
|
Feb 25
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,295
-100.0%
|
$29,785
$23.2 P/Share
|
|
Feb 25
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,295
+50.0%
|
$1,295
$1.44 P/Share
|
|
Feb 24
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,125
-85.88%
|
$51,000
$24.14 P/Share
|
|
Feb 24
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,125
+50.0%
|
$2,125
$1.44 P/Share
|
|
Feb 23
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
465
-100.0%
|
$9,765
$21.84 P/Share
|
|
Feb 23
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
465
+50.0%
|
$465
$1.44 P/Share
|
|
Feb 19
2021
|
Stacy J. Kanter |
BUY
Open market or private purchase
|
Direct |
6,500
+33.33%
|
$143,000
$22.86 P/Share
|
|
Feb 17
2021
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Indirect |
43,478
+1.95%
|
-
|
|
Feb 17
2021
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
43,478
-3.38%
|
-
|
|
Feb 17
2021
|
Alexandria Real Estate Equities, Inc. > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
43,478
+3.27%
|
$999,994
$23.0 P/Share
|
|
Feb 03
2021
|
Riccardo Perfetti Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,295
-76.83%
|
$33,670
$26.83 P/Share
|
|
Feb 03
2021
|
Riccardo Perfetti Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,295
+50.0%
|
$1,295
$1.44 P/Share
|